glp-1 joint pain Drugs: For Multiple Chronic Conditions GLP-1 Inhibitor Reduces Knee Osteoarthritis
Description
Novo's Wegovy pill already has over 600,000 prescriptions since it was approved in December, and Foundayo doesn't require fasting which is a major differentiator
Most patients have it in hand within 5-7 business days
Not for human or animal consumption
Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body mass index, and adverse cardiovascular events
The focus of the Indian pharmaceutical market is increasingly shifting to biologics, including peptides, biosimilars, and GLP-1-based therapies
